Bellevue Group Ag Hutchmed (China) LTD Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
A detailed history of Bellevue Group Ag transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Bellevue Group Ag holds 1,154,632 shares of HCM stock, worth $20.2 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,154,632
Previous 1,131,111
2.08%
Holding current value
$20.2 Million
Previous $20.5 Million
5.31%
% of portfolio
0.3%
Previous 0.32%
Shares
25 transactions
Others Institutions Holding HCM
# of Institutions
69Shares Held
14MCall Options Held
2.7KPut Options Held
3.7K-
General Atlantic LLC New York, NY4MShares$70.1 Million1.57% of portfolio
-
Schroder Investment Management Group London, X03.85MShares$67.4 Million0.08% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.57MShares$27.4 Million0.04% of portfolio
-
Acadian Asset Management LLC Boston, MA487KShares$8.53 Million0.03% of portfolio
-
Aia Group LTD Hong Kong, K3375KShares$6.57 Million0.21% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $3.03B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...